Database administrators are reinventing themselves. Data roams freely, AI is advancing, and governance is lagging behind. Yet ...

Data from a phase 2 trial of Roche's oral BTK inhibitor fenebrutinib have shown "near-complete suppression" of disease activity and disability progression in relapsing multiple sclerosis (MS). The ...

Save big with 11 AI tools offering valuable student discounts, covering study support, productivity, design, and development ...